Molecular status 36 months after TKI discontinuation in CML is highly predictive for subsequent loss of MMR-final report from AFTER-SKI

Richter, J; Lubking, A; Soderlund, S; Lotfi, K; Markevarn, B; Sjalander, A; Stenke, L; Deneberg, S; Ahlstrand, E; Myhr-Eriksson, K; Panayiotidis, P; Gedde-Dahl, T; Zackova, D; Mayer, J; Olsson-Stromberg, U; Mahon, FX; Saussele, S; Hjorth-Hansen, H; Koskenvesa, P

Richter, J (corresponding author), Skane Univ Hosp, Dept Hematol Oncol & Radiat Phys, Lund, Sweden.

LEUKEMIA, ; ():